Skip to Content

  • Search

View Additional Section Content

A Phase II, Multi-Center, Randomized, Parallel Group, Double Blind, Methotrexate, Controlled Study to Assess the Clinical Efficacy, Safety, And Tolerability of CH-4051 in Patients with Active Rheumatoid Arthritis who have shown an Inadequate Response to Methotrexate Monotherapy

Principal Investigator(s)
C. Michael Franklin, M.D. (Sub-Investigator)
Charles H. Pritchard, M.D. (Sub-Investigator)
Mark Lopatin, M.D. (Sub-Investigator)
David J. Chesner, D.O. (Sub-Investigator)
Elana R. Eisner, M.D. (Sub-Investigator)
Marguerite L. McGarvey, M.D.
Dennis A. Jerdan, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Arthritis
Sue Falbo at 215-657-9977


  • Rheumatic Disease Associates, Ltd.

Find a Physician
Search Our Directory


Schedule a


Clinical Trials Details